中興通訊(00763.HK)中標中國聯通IPRAN產品集採項目
中興通訊(00763.HK)官網發文指,中國聯通近日公布2021年IPRAN產品集中採購結果,中興通訊多業務分組平台ZXCTN 9000-EA系列、5G承載智慧接入ZXCTN 6000系列等產品成功中標。本次集採是中國聯通自2020年智能城域網大規模建設之後最大規模的設備集採,覆蓋IPRAN1.0、IPRAN2.0及CPE設備,中標設備將助力中國聯通充分發揮智能城域網業務綜合承載能力,推進新一代雲網融合建設,通過簡化網絡協議,優化流量疏導能力來逐步提升用戶體驗,促進中國數字經濟發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.